Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - CASH & EQUIVALENTS
Cash & Equivalents AXSM - Axsome Therapeutics, Inc.
315 M
LAST VALUE
25.31%
2 YEAR CAGR
7.47%
5 YEAR CAGR
61.47%
10 YEAR CAGR